A flow-based synthesis of Imatinib: the API of Gleevec

    • Mark D. Hopkin
    • Ian R. Baxendale
    • Steven V. Ley
    • Innovative Technology Centre, Department of Chemistry, University of Cambridge

    A concise, flow-based synthesis of Imatinib, a compound used for the treatment of chronic myeloid leukaemia, is described whereby all steps are conducted in tubular flow coils or cartridges packed with reagents or scavengers to effect clean product formation. An in-line solvent switching procedure was developed enabling the procedure to be performed with limited manual handling of intermediates.

    Read the publication that featured this abstract

    Get in touch

    For more information on flow chemistry systems and services please use the contact methods below.

    Call us on +44 (0)1284 728659 or Email us

    Request a quote